000 02386 a2200649 4500
005 20250513093311.0
264 0 _c19960906
008 199609s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.1996.14.8.2353
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGill, P S
245 0 0 _aRandomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cAug 1996
300 _a2353-64 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAcquired Immunodeficiency Syndrome
_xcomplications
650 0 4 _aAdult
650 0 4 _aAlopecia
_xchemically induced
650 0 4 _aAntibiotics, Antineoplastic
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBleomycin
_xadministration & dosage
650 0 4 _aCanada
650 0 4 _aDaunorubicin
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Carriers
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLiposomes
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeutropenia
_xchemically induced
650 0 4 _aProspective Studies
650 0 4 _aRemission Induction
650 0 4 _aSarcoma, Kaposi
_xdrug therapy
650 0 4 _aSurvival Rate
650 0 4 _aTreatment Failure
650 0 4 _aUnited States
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aWernz, J
700 1 _aScadden, D T
700 1 _aCohen, P
700 1 _aMukwaya, G M
700 1 _avon Roenn, J H
700 1 _aJacobs, M
700 1 _aKempin, S
700 1 _aSilverberg, I
700 1 _aGonzales, G
700 1 _aRarick, M U
700 1 _aMyers, A M
700 1 _aShepherd, F
700 1 _aSawka, C
700 1 _aPike, M C
700 1 _aRoss, M E
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 14
_gno. 8
_gp. 2353-64
856 4 0 _uhttps://doi.org/10.1200/JCO.1996.14.8.2353
_zAvailable from publisher's website
999 _c8705971
_d8705971